Abstract
Many biological systems are primarily governed by protein-protein interactions. It is important to develop sensitive analytical techniques to identify and characterize these bimolecular interactions in order to understand their fundamental roles in biological processes and in disease. In this book chapter, we summarize three case studies that applied asymmetrical flow field-flow fractionation (AF4) to access the protein-protein interactions of therapeutic proteins with their counterparts. These new applications of AF4 provide a unique and innovative tool that extends the bioanalytical capability to study protein complexes beyond micro-molar affinity.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Piehler J (2005) New methodologies for measuring protein interactions in vivo and in vitro. Curr Opin Struct Biol 15(1):4–14
Charbonnier S, Gallego O, Gavin A-C (2008) The social network of a cell: recent advances in interactome mapping. Biotechnol Annu Rev 14:1–28
Jefferis R, Lund J (2002) Interaction sites on human IgG-Fc for FcgammaR: current models. Immunol Lett 82:57–65
Hulett MD, Hogarth PM (1994) Molecular basis of Fc receptor function. Adv Immunol 57:1–127
Cao S, Pollastrini J, Jiang Y (2009) Separation and characterization of protein aggregates and particles by field-flow fractionation. Curr Pharm Biotechnol 10:382–390
Giddings JC (1993) Field-flow fractionation: analysis of macromolecular, colloidal, and particulate materials. Science 260:123–125
Cohen-Solal JFG et al (2004) Fcγ receptors. Immunol Lett 92:199–205
Murphy RM et al (2006) Self-association of therapeutic proteins. In: Misbehaving proteins. Springer, New York, pp 313–333
Philo JS (1999) Overview of the quantitation of protein intercations. In: Current protocols in protein science. Wiley, New York, pp 20.1.1–20.1.13
Schuck P et al (1999) Sedimentation equilibrium analysis of recombinant mouse FcRn with murine IgG1. Mol Immunol 36:1117–1125
Pollastrini J, Dillon TM, Bondarenko P, Chou RY-T (2011) Field-flow fractionation for assessing neonatal Fc receptor and Fcγ receptor binding to monoclonal antibodies in solution. Anal Biochem 414:88–98
Anderson CL et al (2006) Perspective – FcRn transports albumin: relevance to immunology and medicine. Trends Immunol 27(7):343–348
Lencer WI, Blumberg RS (2005) A passionate kiss, then run: exocytosis and recycling of IgG by FcRn. Trends Cell Biol 15(1):5–9
Salfeld JG (2007) Isotype selection in antibody engineering. Nat Biotechnol 25(12):1369–1372
Nimmerjahn F, Ravetch JV (2008) Fc[gamma] receptors as regulators of immune responses. Nat Rev Immunol 8(1):34–47
Raghavan M, Bjorkman PJ (1996) Fc receptors and their interactions with immunoglobulins. Annu Rev Cell Dev Biol 12(1):181–220
Roopenian DC, Akilesh S (2007) FcRn: the neonatal Fc receptor comes of age. Nat Rev Immunol 7(9):715–725
Chaudhury C et al (2006) Albumin binding to FcRn: distinct from the FcRn-IgG interaction. Biochemistry 45(15):4983–4990
Vaughn DE, Bjorkman PJ (1997) High-affinity binding of the neonatal Fc receptor to its IgG ligand requires receptor immobilization. Biochemistry 36:9374
Andersen JT, Dee Qian J, Sandlie I (2006) The conserved histidine 166 residue of the human neonatal Fc receptor heavy chain is critical for the pH-dependent binding to albumin. Eur J Immunol 36(11):3044–3051
Firan M et al (2001) The MHC class I-related receptor, FcRn, plays an essential role in the maternofetal transfer of {gamma}-globulin in humans. Int Immunol 13(8):993–1002
West AP, Bjorkman PJ (2000) Crystal structure and immunoglobulin G binding properties of the human major histocompatibility complex-related Fc receptor. Biochemistry 39(32):9698–9708
Martin WL, Bjorkman PJ (1999) Characterization of the 2:1 complex between the class I MHC-related Fc receptor and its Fc ligand in solution. Biochemistry 38:12639
Raghavan M et al (1995) Analysis of the pH dependence of the neonatal Fc receptor/immunoglobulin G interaction using antibody and receptor variants. Biochemistry 34(45):14649–14657
Rodewald R (1976) pH-dependent binding of immunoglobulins to intestinal cells of the neonatal rat. J Cell Biol 71(2):666–669
Popov S et al (1996) The stoichiometry and affinity of the interaction of murine Fc fragments with the MHC class I-related receptor, FcRn. Mol Immunol 33(6):521–530
Junghans RP, Anderson CL (1996) The protection receptor for IgG catabolism is the beta2-microglobulin-containing neonatal intestinal transport receptor. Proc Natl Acad Sci USA 93(11):5512–5516
Chaudhury C et al (2003) The major histocompatibility complex-related Fc receptor for IgG (FcRn) binds albumin and prolongs its lifespan. J Exp Med 197:315
Kharitonenkov A, Shiyanova TL, Koester A, Ford AM, Micanovic R, Galbreath EJ, Sandusky GE, Hammond LJ, Moyers JS, Owens RA, Gromada J, Brozinick JT, Hawkins ED, Wroblewski VJ, Li DS, Mehrbod F, Jaskunas SR, Shanafelt AB (2005) FGF-21 as a novel metabolic regulator. J Clin Invest 115:1627–1635
Xu J, Stanislaus S, Chinookoswong N, Lau YY, Hager T, Patel J, Ge H, Weiszmann J, Lu SC, Graham M, Busby J, Hecht R, Li YS, Li Y, Lindberg RA, Veniant MM (2009) Acute glucose-lowering and insulin-sensitizing action of FGF21 in insulin resistant mouse models––association with liver and adipose tissue effects. Am J Physiol 297:E1105–E1114
Kharitonenkov A, Wroblewski VJ, Koester A, Chen YF, Clutinger CK, Tigno XT, Hansen BC, Shanafelt AB, Etgen GJ (2007) The metabolic state of diabetic monkeys is regulated by fibroblast growth factor-21. Endocrinology 148:774–781
Kharitonenkov A, Dunbar JD, Bina HA, Bright S, Moyers JS, Zhang C, Ding L, Micanovic R, Mehrbod SF, Knierman MD, Hale JE, Coskun T, Shanafelt A (2008) FGF-21/FGF-21 receptor interaction and activation is determined by beta Klotho. J Cell Physiol 215:1–7
Yie J, Hecht R, Patet J, Stevens J, Wang W, Hawkins N, Steavenson S, Smith S, Winters D, Fisher S, Cai L, Belouski E, Ching C, Michaels M, Li Y, Lindberg R, Wang M, Veniant M, Xu J (2009) FGF21 N- and C-termini play different roles in receptor interaction and activation. FEBS Lett 583:19–24
Park I et al (2002) Separation and selective detection of lipoprotein particles of patients with coronary artery disease by frit-inlet asymmetrical flow field-flow fractionation. J Chromatogr B 780(2):415–422
Rambaldi DC et al (2007) An analytical method for size and shape characterization of blood lipoproteins. Clin Chem 53(11):2026–2029
Park I et al (2005) Performance of hollow-fiber flow field-flow fractionation in protein separation. J Sep Sci 28(16):2043–2049
Madörin M et al (1997) Analysis of drug/plasma protein interactions by means of asymmetrical flow field-flow fractionation. Pharm Res 14(12):1706–1712
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2012 Springer-Verlag/Wien
About this chapter
Cite this chapter
Chou, R.YT. et al. (2012). Field-Flow Fractionation for Assessing Biomolecular Interactions in Solution. In: Williams, S., Caldwell, K. (eds) Field-Flow Fractionation in Biopolymer Analysis. Springer, Vienna. https://doi.org/10.1007/978-3-7091-0154-4_8
Download citation
DOI: https://doi.org/10.1007/978-3-7091-0154-4_8
Published:
Publisher Name: Springer, Vienna
Print ISBN: 978-3-7091-0153-7
Online ISBN: 978-3-7091-0154-4
eBook Packages: Chemistry and Materials ScienceChemistry and Material Science (R0)